Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wanner

Showing results (11-20 of 206) with videos related to

Pageof 21
Sort By:
Der Internist|October 27, 1998
[Proteinuria]H Naujoks, C Wanner
The Clinical Investigator|August 1, 1994
Lipoprotein(a): new insights into an atherogenic lipoproteinW Bartens, C Wanner
Deutsche Medizinische Wochenschrift (1946)|October 2, 2012
[Chronic kidney disease]M Ketteler, C Wanner
Deutsche Medizinische Wochenschrift (1946)|November 4, 1994
[Gallbladder sludge and the taking of lipid-lowering agents]T Kirschner, C Wanner
Deutsche Medizinische Wochenschrift (1946)|January 30, 2014
[Chronic kidney disease--update 2014]C Wanner, M Ketteler
Der Internist|February 13, 2020
[Treatment of coronary artery disease in renal insufficiency]K Lopau, C Wanner
Contributions to Nephrology|January 1, 1997
Effects of lipoprotein (a) on mesangial cell biologyS Greiber, C Wanner
MMW Fortschritte Der Medizin|May 4, 2006
[Treatment of dyslipoproteinemia in chronic renal failure]V Krane, C Wanner
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 1998
Oxidative stress and vascular injury--relevant for atherogenesis in uraemic patients?J Galle, C Wanner
Mineral and Electrolyte Metabolism|January 1, 1997
Lipoprotein(a) in nephrotic syndrome and end-stage renal diseaseS Greiber, C Wanner
Pageof 21

Showing results (11-20 of 206) with videos related to

Sort By:
Pageof 21
Der Internist|October 27, 1998
[Proteinuria]H Naujoks, C Wanner
The Clinical Investigator|August 1, 1994
Lipoprotein(a): new insights into an atherogenic lipoproteinW Bartens, C Wanner
Deutsche Medizinische Wochenschrift (1946)|October 2, 2012
[Chronic kidney disease]M Ketteler, C Wanner
Deutsche Medizinische Wochenschrift (1946)|November 4, 1994
[Gallbladder sludge and the taking of lipid-lowering agents]T Kirschner, C Wanner
Deutsche Medizinische Wochenschrift (1946)|January 30, 2014
[Chronic kidney disease--update 2014]C Wanner, M Ketteler
Der Internist|February 13, 2020
[Treatment of coronary artery disease in renal insufficiency]K Lopau, C Wanner
Contributions to Nephrology|January 1, 1997
Effects of lipoprotein (a) on mesangial cell biologyS Greiber, C Wanner
MMW Fortschritte Der Medizin|May 4, 2006
[Treatment of dyslipoproteinemia in chronic renal failure]V Krane, C Wanner
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 1998
Oxidative stress and vascular injury--relevant for atherogenesis in uraemic patients?J Galle, C Wanner
Mineral and Electrolyte Metabolism|January 1, 1997
Lipoprotein(a) in nephrotic syndrome and end-stage renal diseaseS Greiber, C Wanner
Pageof 21